- Home
- HTCO vs IXHL Comparison
HTCO vs IXHL Comparison
Compare HTCO & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTCO
- IXHL
- Stock Information
- Founded
- HTCO 2022
- IXHL 2001
- Country
- HTCO Singapore
- IXHL Australia
- Employees
- HTCO N/A
- IXHL N/A
- Industry
- HTCO
- IXHL
- Sector
- HTCO
- IXHL
- Exchange
- HTCO NYSE
- IXHL Nasdaq
- Market Cap
- HTCO 22.8M
- IXHL 20.2M
- IPO Year
- HTCO N/A
- IXHL N/A
- Fundamental
- Price
- HTCO $0.22
- IXHL $0.22
- Analyst Decision
- HTCO
- IXHL
- Analyst Count
- HTCO 0
- IXHL 0
- Target Price
- HTCO N/A
- IXHL N/A
- AVG Volume (30 Days)
- HTCO 2.0M
- IXHL 41.9M
- Earning Date
- HTCO 01-01-0001
- IXHL 05-15-2025
- Dividend Yield
- HTCO N/A
- IXHL N/A
- EPS Growth
- HTCO N/A
- IXHL N/A
- EPS
- HTCO N/A
- IXHL N/A
- Revenue
- HTCO $108,176,683.00
- IXHL $98,000.00
- Revenue This Year
- HTCO N/A
- IXHL $3,817.06
- Revenue Next Year
- HTCO N/A
- IXHL $66.67
- P/E Ratio
- HTCO N/A
- IXHL N/A
- Revenue Growth
- HTCO 13.56
- IXHL N/A
- 52 Week Low
- HTCO $0.18
- IXHL $0.08
- 52 Week High
- HTCO $4.50
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- HTCO N/A
- IXHL 49.20
- Support Level
- HTCO N/A
- IXHL $0.20
- Resistance Level
- HTCO N/A
- IXHL $0.23
- Average True Range (ATR)
- HTCO 0.00
- IXHL 0.02
- MACD
- HTCO 0.00
- IXHL 0.01
- Stochastic Oscillator
- HTCO 0.00
- IXHL 51.46
About HTCO CARAVELLE INTERNATIONAL GROUP
High-Trend International Group formerly Caravelle International Group is an international operator of ocean transportation services. It is engaged in the seaborne transportation service under voyage contracts as well as vessel service for and on behalf of ship owners. The company has two operating segments namely, ocean transport and Heating business. The company derives the majority of its revenue from the Ocean transportation business. The company derives freight revenue from voyage contracts and provides vessel service. Majority of revenue is from providing shipping services for customers in Asia, principally in Singapore, Dubai, Korea, Japan, and India.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.